Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd.

Shanxi Sanbao Group is an economic entity that integrates pharmaceutical R&D and manufacturing with real estate development and implements diversified development. The group is mainly composed of four major sectors: pharmaceutical R&D and manufacturing, domestic and foreign trade, construction and real estate development. Shanxi Sanbao Group was founded in 2006. Since its establishment, the group has given full play to the group's venture capital research and development and resource coordination, strategic decision-making functions and scale advantages, providing necessary liquidity and stability support for subsidiaries, and the operating advantages of each company have been fully utilized. , Provide strong support for the economic transformation of enterprises and the construction of large projects.

Visit Website

Manufacturer

Zhao Nannan(CEO)

APIs,Granules

Above 10M USD

101-500 people

10

Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd., a subsidiary of Shanxi Sanbao Group, operates at the forefront of pharmaceutical research, development, and manufacturing. Established within the Kangzhuang Industrial Park in Tunliu County, Changzhi City, Shanxi Province, the company specializes in producing a wide array of pharmaceutical products. These include Active Pharmaceutical Ingredients (APIs), granules, small volume injections, tablets, syrups, eye drops, Chinese medicine extractions, sterile APIs, and cephalosporin APIs. Since its inception in 2006, Shanxi Sanbao Group has leveraged its expertise in pharmaceutical R&D alongside real estate development and international trade sectors. This strategic integration has fortified the group's economic foundation, enabling it to contribute significantly to regional economic transformation and large-scale project developments. Led by Zhao Nannan, Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd. exemplifies a commitment to innovation and operational excellence. The company benefits from substantial resources and strategic decision-making capabilities inherent within Shanxi Sanbao Group, ensuring robust support for subsidiary operations. With a workforce ranging between 101 to 500 employees, the company maintains a strong focus on quality assurance and regulatory compliance. Located at No. 3 Kangzhuang Avenue, the company continues to expand its product portfolio and market presence, serving both domestic and international markets with high-quality pharmaceutical solutions.